UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis

Clinical therapeutics, 2016-12, Vol.38 (12), p.2654-2664.e1

2016

Volltextzugriff (PDF)

Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome

International Journal of Endocrinology, 2016-01, Vol.2016 (2016), p.749-754-083

2016

Volltextzugriff (PDF)

Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study

International Journal of Endocrinology, 2015-01, Vol.2015 (2015), p.286-290-235

2015

Volltextzugriff (PDF)

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)

Diabetes care, 2017-07, Vol.40 (7), p.943-950

2017

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol

Diabetes, obesity & metabolism, 2019-10, Vol.21 (10), p.2192-2202

2019

Volltextzugriff (PDF)

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

Diabetes care, 2016-10, Vol.39 (10), p.1702-1710

2016

Volltextzugriff (PDF)

Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes

Canadian journal of diabetes, 2020-02, Vol.44 (1), p.61-67

Woo, Vincent C.

2020

Volltextzugriff (PDF)

The Celebration of Daily Mass with No Faithful Present after Vatican II

The Jurist (Washington), 2024, Vol.80 (1), p.53-83

Woo, Vincent W.

2024

Volltextzugriff (PDF)

A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus

Clinical therapeutics, 2017-08, Vol.39 (8), p.S12-S33

Woo, Vincent C., MD, FRCPC

2017

Volltextzugriff (PDF)

Historical Development of the Times of Ordinations: A Proposal to Revitalize Ember Saturday Ordinations

The Jurist (Washington), 2023, Vol.79 (2), p.459-506

Woo, Vincent W.

2023

Volltextzugriff (PDF)

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

Diabetes care, 2009-04, Vol.32 (4), p.650-657

2009

Volltextzugriff (PDF)

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

The Lancet (British edition), 2015-05, Vol.385 (9982), p.2057-2066

2015

Volltextzugriff (PDF)

Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia

Journal of psychopharmacology (Oxford), 2018-05, Vol.32 (5), p.509-523

2018

Volltextzugriff (PDF)

Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report

British journal of clinical pharmacology, 2019-04, Vol.85 (4), p.690-703

2019

Volltextzugriff (PDF)

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

Diabetologia, 2018-01, Vol.61 (1), p.58-65

2018

Volltextzugriff (PDF)

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?

Diabetes, obesity & metabolism, 2020-04, Vol.22 (4), p.631-639

2020

Volltextzugriff (PDF)

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

The lancet. Diabetes & endocrinology, 2014-11, Vol.2 (11), p.885-893

2014

Volltextzugriff (PDF)

Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

Obesity reviews, 2024-03, Vol.25 (3), p.e13663-n/a

2024

Volltextzugriff (PDF)

856-P: Cardiovascular (CV) and Kidney Outcomes with Canagliflozin (CANA) According to Type 2 Diabetes (T2D) Treatment Targets at Baseline (BL) : Data from the CANVAS Program and CREDENCE

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

134-LB: Real-World Impact of Intermittently Scanned Continuous Glucose Monitoring on Hemoglobin A1c in People with Type 2 Diabetes in Canada That Use Basal Insulin—A Prospective Chart Review

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

964-P: Glycemic and Body Weight Responses to Oral Semaglutide in the PIONEER Trial Program

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study

Diabetes & vascular disease research, 2024-05, Vol.21 (3), p.14791641241253967-14791641241253967

2024

Volltextzugriff (PDF)

Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting

Diabetes, obesity & metabolism, 2018-05, Vol.20 (5), p.1316-1320

2018

Volltextzugriff (PDF)

New Insulins and New Aspects in Insulin Delivery

Canadian journal of diabetes, 2015-08, Vol.39 (4), p.335-343

Woo, Vincent C., MD, FRCPC

2015

Volltextzugriff (PDF)

Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unit

International psychogeriatrics, 2022-10, Vol.34 (10), p.919-928

2022

Volltextzugriff (PDF)

1 – 25 von 719

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(645)
Mit Volltextzugriff
(620)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(441)
Life Sciences & Biomedicine
(358)
Humans
(305)
Female
(187)
Male
(183)
Middle Aged
(140)
Aged
(124)
Adult
(108)
Endocrinology & Metabolism
(98)
Diabetes
(62)
Treatment Outcome
(60)
Animals
(53)
Microbiology
(52)
Biological And Medical Sciences
(51)
Infectious Diseases
(49)
Other
(49)
Risk Factors
(48)
Diabetes Mellitus
(47)
Diabetes Mellitus, Type 2 - Drug Therapy
(45)
Technology
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Canadian Journal Of Diabetes
(89)
Journal Of Vascular Surgery
(19)
Plos One
(16)
Neurology
(14)
Clinical Infectious Diseases
(12)
Diabetes Care
(12)
Diabetes, Obesity & Metabolism
(12)
Nature
(11)
Journal Of The American College Of Cardiology
(10)
The Lancet
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis

Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome

Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)

Sodium‐glucose co‐transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes

The Celebration of Daily Mass with No Faithful Present after Vatican II

A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus

Historical Development of the Times of Ordinations: A Proposal to Revitalize Ember Saturday Ordinations

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia

Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

856-P: Cardiovascular (CV) and Kidney Outcomes with Canagliflozin (CANA) According to Type 2 Diabetes (T2D) Treatment Targets at Baseline (BL) : Data from the CANVAS Program and CREDENCE

134-LB: Real-World Impact of Intermittently Scanned Continuous Glucose Monitoring on Hemoglobin A1c in People with Type 2 Diabetes in Canada That Use Basal Insulin—A Prospective Chart Review

964-P: Glycemic and Body Weight Responses to Oral Semaglutide in the PIONEER Trial Program

Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study

Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting

New Insulins and New Aspects in Insulin Delivery

Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unit

Suchergebnisse filtern